Rutgers School of Public Health

Rutgers COVID-19 Center Names Associate Director for Public Health

Henry F. Raymond, associate professor in the department of biostatistics and epidemiology at the Rutgers School of Public Health, will serve as the associate director for public health.
6-Apr-2020 12:05 PM EDT, by Rutgers School of Public Health

Newswise — The Rutgers COVID Response Pandemic Preparedness Center, which is coordinating the university’s myriad research, public health, and outreach efforts to combat COVID-19, has named Henry F. Raymond, associate professor in the department of biostatistics and epidemiology at the Rutgers School of Public Health, as it’s associate director for public health. 

Raymond will lead the center’s public health initiatives, including coordinating public health-related COVID-19 research at Rutgers and collaborations between the university and external partners. He will also serve as the principal advisor and communicator on public health-related matters.

Raymond, an epidemiologist who bridges academic research and public health practice, both domestically and internationally, focuses his research on populations at high risk for HIV infection - including men who have sex with men, people who inject drugs, trans women, prisoners, migrant populations and female sex workers - LGBT populations, hepatitis C infection, health disparities, and social determinants of health.  He has been consistently funded by the Centers for Disease Control and Prevention, National Institutes of Health, and the Department of Defense, to whom he regularly provides expert advice on novel epidemiological methods.

Currently, Raymond is working closely with the New Jersey Department of Health on HIV and hepatitis issues. He has also been actively involved in explaining COVID-19 epidemiological concepts to the general public by speaking to local, state, and national media outlets. 

“I’m very excited that Henry F. Raymond will be serving as the associate director for public health at the COVID Response Pandemic Preparedness Center,” said David Alland, center director and chief of infectious disease at New Jersey Medical School. “Dr. Raymond will be an excellent partner, providing crucial public health and epidemiological expertise.”

The center, which was developed in response to the COVID-19 pandemic, uses strengths that collectively are unique to the university. These strengths include the Rutgers Institute for Infectious and Inflammatory Diseases (i3D), a global leader in infectious disease research; NJMS/i3D biosafety level 3 laboratories that are equipped to study dangerous pathogens; world-class, health-related schools that include medicine, nursing, pharmacy, public health, dentistry and health professions, in addition to several renowned centers and institutes; world-class engineering, computational sciences, social sciences, business, law, artificial intelligence and machine learning capabilities; and the Rutgers Institute for Translational Medicine and Science, which facilitates clinical and translational research via several research cores.

“Henry F. Raymond possess extensive hands-on experience working with local, state, and global departments of health on infectious disease surveillance,” said Perry N. Halkitis, dean of the Rutgers School of Public Health. “His epidemiological skills, coupled with his experience, perfectly situate him for this role.”

“I look forward to working with colleagues from across the university and our private and community partners to expand upon the center’s work by providing a public health perspective that is rooted in social justice and health equity,” added Raymond. 



The Rutgers School of Public Health is New Jersey’s leading academic institution in public health that is committed to advancing health and wellbeing and preventing disease throughout New Jersey, the United States, and the world, by preparing students as public health leaders, scholars, and practitioners; conducting public health research and scholarship; engaging collaboratively with communities and populations; and actively advocating for policies, programs, and services through the lens of equity and social justice. Learn how the Rutgers School of Public Health is "keeping the ‘public’ in public health,” by visiting them at  

Filters close

Showing results

110 of 2478
Released: 7-Jul-2020 2:05 PM EDT
Law clinic wins access to COVID-19 race data
Cornell University

The First Amendment Clinic at Cornell Law School, working on behalf of its client, The New York Times, helped secure the release of previously unseen data that provides the most detailed look yet at nearly 1.5 million American coronavirus patients from 974 counties across the country.

Released: 7-Jul-2020 2:00 PM EDT
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors (PPIs)
American College of Gastroenterology (ACG)

Findings from an online survey of more than 53,000 American adults suggest that using heartburn medications known as proton pump inhibitors (PPIs) once or twice daily significantly increases the odds of a positive test for COVID-19 compared to those who do not take PPIs. This research appeared online July 7, 2020 in pre-print format in The American Journal of Gastroenterology.

Released: 7-Jul-2020 1:40 PM EDT
COVID-related discrimination disproportionately impacts racial minorities, study shows
University of Southern California (USC)

Discrimination against people thought to be infected with coronavirus was experienced by a rising number of United States residents, particularly racial minorities, in the early stages of the COVID-19 pandemic, according to a new study from the USC Dornsife College of Letters, Arts and Sciences.

Newswise: 236726_web.jpg
Released: 7-Jul-2020 1:10 PM EDT
A chemical cocktail of air pollution in Beijing, China during COVID-19 outbreak
Institute of Atmospheric Physics, Chinese Academy of Sciences

The novel coronavirus disease (COVID-19) spreads rapidly around the world, and has limited people's outdoor activities substantially.

Released: 7-Jul-2020 12:50 PM EDT
Remdesivir can save more lives where ICUs are overwhelmed
Boston University School of Medicine

Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning to overwhelm intensive care units (ICUs).

Newswise: Cedars-Sinai Named Age-Friendly Health System
Released: 7-Jul-2020 12:40 PM EDT
Cedars-Sinai Named Age-Friendly Health System

Shortly after COVID-19 was declared a pandemic, more than 450 older adults learned their weekly exercise classes offered through the Cedars-Sinai Geriatrics Program were on hold. But under the quick-thinking direction of geriatrician Allison Moser Mays, MD, the program pivoted, creating a way for seniors to access live classes over Zoom from the comfort of their homes. The online format has proved especially popular.

Newswise: WashU Expert: Eviction moratoriums are incomplete solution
Released: 7-Jul-2020 11:55 AM EDT
WashU Expert: Eviction moratoriums are incomplete solution
Washington University in St. Louis

Millions of tenants are at risk of eviction as protections in the CARES Act are set to expire. While the U.S. Congress and Senate are proposing plans to extend the federal moratorium on evictions, a finance expert at Washington University in St. Louis warns that is just one piece of the puzzle.

Released: 7-Jul-2020 11:40 AM EDT
Beaumont researchers develop COVID-19 test that can detect virus in saliva, blood or urine in 45 minutes
Beaumont Health

Rapid test for COVID-19 can help contain the virus and contribute to a successful reopening of the economy

Released: 7-Jul-2020 11:15 AM EDT
Study: surgical delay associated with increased risk in some gastrointestinal malignancies
Beth Israel Deaconess Medical Center

Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or “non-emergency” operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, including cancer, timely surgery is critical for patients’ survival. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of delaying surgery for gastrointestinal cancers.

Newswise: GettyImages%20Sickle%20Cell.jpg
Released: 7-Jul-2020 9:35 AM EDT
COVID-19: What you should know if you have sickle cell disease
LifeBridge Health

If you have sickle cell disease, you are at higher risk than the general population for severe complications from COVID-19.

Showing results

110 of 2478